11/7/2023 | 38229090 | EP-ICRS1552-ABACAVIR SUIFATE FOR SYSTEM SUITABILITY RS-(10MG)-(PHARMACEUTICAL REFERENCE STANDARD) | COUNCIL OF EUROPE/ CONSEIL DE I'EUROPE | 2 | NOS | 156.56 | FRANCE | BANGALORE ACC |
8/29/2023 | 38229010 | Y0001551 ABACAVIR FOR SYSTEM SUITABILITY CRS(10MG)(CERTIFIEDREFERANCE STANDARDS) | COUNCIL OF EUROPE(EDQM) | 1 | NOS | 91.02 | FRANCE | BANGALORE ACC |
8/29/2023 | 38229090 | EP-ICRS1552-ABACAVIR SUIFATE FOR SYSTEM SUITABILITY RS-(10MG)-(PHARMACEUTICAL REFERENCE STANDARD) | COUNCIL OF EUROPE/ CONSEIL DE I'EUROPE | 5 | NOS | 405.11 | FRANCE | BANGALORE ACC |
8/19/2023 | 38229010 | Y0001551 ABACAVIR FOR SYSTEM SUITABILITY CRS(10MG)(CERTIFIEDREFERANCE STANDARDS) | COUNCIL OF EUROPE(EDQM) | 1 | NOS | 91.02 | FRANCE | BANGALORE ACC |
6/20/2023 | 38229090 | EP-ICRS1552-ABACAVIR SUIFATE FOR SYSTEM SUITABILITY RS-10MG-PHARMACEUTICAL REFERENCE STANDARD | COUNCIL OF EUROPE CONSEIL DE | 3 | NOS | 234.83 | France | BANGALORE AIR |
6/3/2023 | 38229010 | Y0001551-Abacavir for system suitability CRS-10mgCERTIFIED REFERENCE STANDARDS | COUNCIL OF EUROPE EDQM | 1 | NOS | 87.33 | France | BANGALORE AIR |
5/16/2023 | 38229090 | EP-ICRS1552-ABACAVIR SULFATE FOR SYSTEM SUITABILITY RS-(10MG)-(PHARMACEUTICAL REFERENCE STANDARD) | COUNCIL OF EUROPE/ CONSEIL DE I'EUROPE | 1 | NOS | 81.21 | FRANCE | BANGALORE ACC |